Acute effect of Capparis spinosa root extracts on rat articular pain by Maresca, Mario et al.
Journal of Ethnopharmacology 193 (2016) 456–465Contents lists available at ScienceDirectJournal of Ethnopharmacologyhttp://d
0378-87
n Corr
E-mjournal homepage: www.elsevier.com/locate/jepAcute effect of Capparis spinosa root extracts on rat articular pain
Mario Maresca a, Laura Micheli a, Lorenzo Di Cesare Mannelli a,n, Barbara Tenci a,
Marzia Innocenti b, Mohamad Khatib b, Nadia Mulinacci b, Carla Ghelardini a
a Department of Neuroscience, Psychology, Drug Research and Child Health – NEUROFARBA – Pharmacology and Toxicology Section, University of Florence,
Florence, Italy
b Department of Neuroscience, Psychology, Drug Research and Child Health – NEUROFARBA – Pharmaceutical and Nutraceutical Division, University of
Florence, Florence, Italya r t i c l e i n f o
Article history:
Received 11 March 2016
Received in revised form
30 July 2016
Accepted 16 September 2016
Available online 17 September 2016
Keywords:
Caper root
Spermidine alkaloids
Stachydrine
CFA
MIA
Rheumatoid arthritis
Osteoarthritisx.doi.org/10.1016/j.jep.2016.09.032
41/& 2016 Elsevier Ireland Ltd. All rights rese
esponding author.
ail address: lorenzo.mannelli@unifi.it (L. Di Cea b s t r a c t
Ethnopharmacological relevance: Capparis spinosa L. originates from dry regions of Asia and Mediterra-
nean basin. In traditional medicine of these areas, infusions from caper root are considered to be ben-
eficial for the treatment of rheumatism, gout and against abdominal pains.
Aim of the study: To evaluate the pain relieving properties of a Syrian cultivar of Capparis spinosa roots in
rat models of osteoarthritis and rheumatoid arthritis.
Materials and methods: Decoction (DEC) and hydroalcoholic extract (EtH2O) were obtained from pow-
dered roots; the latter was further separated in CH2Cl2 and aqueous (H2O-Res) fractions. The extracts
were characterized in terms of spermidine alkaloids by HPLC/DAD/MS and stachydrine by NMR. Different
amount of free and glycosilated forms of capparispine and analogues (from 0.5% w/w for DEC up to 7.6%
w/w for CH2Cl2 fraction) were detected. Rat models of rheumatoid arthritis and osteoarthritis were in-
duced by the intra-articular administration of Complete Freund's Adjuvant (CFA) or monosodium io-
doacetate (MIA), respectively.
Results: Fourteenth days after CFA or MIA injection, the different preparations of Capparis spinosa (3, 30,
100 and 300 mg kg1) were acutely administered p.o.. Powdered roots (300 mg kg1), DEC
(100 mg kg1), and EtH2O (300 mg kg1) significantly reduced hypersensitivity to mechanical noxious
stimuli as well as spontaneous pain evaluated as hind limb bearing alterations in both models. The
CH2Cl2 and the H2O-Res (30 mg kg1) were the most potent in reverting pain threshold alterations
despite the different content of free alkaloids.
Conclusions: Capparis spinosa extracts relieved pain related to rheumatoid arthritis and osteoarthritis
after single administration. A synergistic effect due to a specific “phytochemical mixture” is suggested.
& 2016 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Rheumatoid arthritis and osteoarthritis are the most common
articular diseases in adults (Goldring and Marcu, 2009). Synovial
inflammation, necrosis of chondrocytes and the consequent de-
struction of cartilage characterize the pathologies (Mullen et al.,
2015; Sangha, 2000). Both lead to joint degeneration and are ex-
tremely painful (Bijlsma et al., 2011; Scott et al., 2010).
Capparis spinosa L. (Capparidaceae) is a plant originating from
dry regions in west or central Asia and particularly spread across
the Mediterranean basin (Baytop, 1984; Çalis et al., 1999; Tlili et al.,
2011). The traditional use of Capparis spinosa roots against differ-
ent types of pain in human is well known since the antiquity (Jiangrved.
sare Mannelli).et al., 2007). Several authors (Al-Said et al., 1988; Sher and Alye-
meni, 2010) reported that, in traditional medicine, infusions made
from caper are considered to be beneficial for the treatment of
rheumatism, gout and abdominal pains; moreover, pastes are used
for topic applications to treat swollen joints, skin rashes and burns
(Eddouks et al., 2004; Inocencio et al., 2002). The anti-nociceptive
and anti-inflammatory properties of Capparis are described in
different animal models (Arslan et al., 2010; Zhou et al., 2010). In
particular, flowering buds and fruits of Capparis spinosa have
shown significant anti-inflammatory and anti-oxidant effects in
both in vivo and in vitro model of articular damage (Feng et al.,
2011; Panico et al., 2005). Even though the aerial parts of the plant,
such as flowers, leaves and fruits are rather studied, less attention
has been devoted to the roots of Capparis spinosa. In the Syrian
tradition, the powdered root is widely used by oral administration
or topical applications on the painful part of “dough” prepared
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root bark are macerated and placed between gauze on aching area
for 15–25 min in order to relieve inflammation and muscle pain
(Hudaib et al., 2008). Regarding the root composition it has been
reported the presence of alkaloids belonging to the spermidine
group (Fu et al., 2008) together with the presence of stachydrine, a
more polar alkaloid typical of the caper leaves too (Batanouny and
Drissamnauer, 2005; Buckingham, 1994). Interestingly, the use of
polyamine alkaloids, as those of the spermidine group, has been
suggested as efficacious in arthritis disease (Iezaki et al., 2012).
The aim of the present research is the improvement of
knowledge about the phytochemical and pharmacological profile
of caper root. A Syrian sample of C. spinosa root was selected to
prepare four different extracts containing alkaloids in order to
evaluate their ability in relieving osteoarticular pain. A determi-
nation of the alkaloid content was carried out before the in vivo
tests. The powered root and the extracts were acutely adminis-
tered at different dosages, in animal models of rheumatoid ar-
thritis and osteoarthritis.2. Materials and methods
2.1. Root sample
The roots of Capparis spinosa L. (Capparaceae; the plant name
has been checked with www.theplantlist.org) were collected from
KafrNabl, province of Idlib, in the north of Syria, the sample was
authenticated by a member of the General Commission for Sci-
entific Agricultural Research, Damascus, Syria. The roots were
freeze-dried as whole (1 kg as total) within two weeks after har-
vest and maintained at room temperature in dark until analyses.
2.2. Extracts preparation from whole root
All the extracts were done using 12 g of fine powdered root and
applying the same drug/solvent extraction ratio: 1:30 w/v. The
decoction (DEC) was prepared using distilled water under stirring
for 1 h, at boiling. After cooling and filtration the supernatant was
collected, treated with ethanol (0.72 L) and kept for 3 h at 0 °C to
precipitate and remove the crude polysaccharides. After filtration
the hydroalcholic solution was dried by rotavapor to obtain DEC
sample (about 3 g dw). The hydroalcoholic extraction was per-
formed using ethanol/water mixture (7:3 v/v). The first step was a
sonication of 30 min (35 MHz), then two successive extractions,
each of 12 h under magnetic stirring at room temperature, were
applied. The hydroalcoholic solutions were recovered after filtra-
tion through Whatman filter paper, then gathered together and
dried by rotavapor to obtain EtH2O sample.
To selectively recover the alkaloids a new hydroalcoholic ex-
tract was prepared as described before, but avoiding the final
drying. The ethanol was then removed from the sample by rota-
vapor (t below 30 °C), and to the aqueous residue (close to 100 mL)
was added with NH3 until pH 10.
A liquid-liquid extraction with CH2Cl2 (1002 mL) was applied
to treat the alkaline solution, the organic phases were gathered
together and dried by rotavapor to obtain CH2Cl2 extract. The re-
maining water residue was freeze-dried to obtain H2O-Res sample.
The four extracts previously described were used for the animal
tests.
2.3. HPLC-MS and MSn experiments
All the dried extracts were redissolved in ethanol/water mix-
tures to obtain suitable samples for the HPLC analyses.
HPLC-MS and MSn experiments were done in positive modeusing two different MS detectors and applying the same elution
method. The column was a Fusion with pre-column A
150 mm2 mm i.d., 4 μm, 80 Å (Phenomenex, Torrance, CA, USA);
the mobile phases were (A) 0.1% formic acid/water and (B) CH3CN.
All solvents used were HPLC grade; CH3CN was from E. Merck
(Darmstadt, Germany). A multi-step linear solvent gradient was
applied: 0–2 min 2% B; 2–20 min, 2–25% B; 20–25 min 25–35% B;
25–28 min 35–95% B; 28–32 min 95–95% with a final plateau of
2 min at 2% B; equilibration time 10 min; flow rate 0.4 mL min1
and oven temperature 26 °C; injection volume 5 μL.
The UHPLC was a Platin Blue (Knauer, Berlin, Germany), oper-
ating in the same condition as described for HPLC-DAD analyses.
The UHPLC was directly connected to a LTQ linear quadrupole ion
trap mass spectrometer (Thermo Scientific, Bremen, Germany) via
an ESI interface. The analyses were performed in scan mode in the
range 134–800 m/z, alternating the two polarities. The following
MS parameters were used: spray voltage 4700 V, capillary voltage
20 V, tube lens offset 90 V in positive ion mode, and spray voltage
–4400 V, capillary voltage 40 V, tube lens offset 55 V in ne-
gative ion mode. Nitrogen was used as the sheath, sweep and
auxiliary gas at 28, 6 and 4 (arbitrary units), respectively; capillary
temperature was 295 °C.
The MS/MS and MS/MS/MS experiments were performed on
some selected precursor ions in positive ion mode, at m/z 144.1,
598.3 and 436.2 m/z as previously described (Khatib et al., 2016).
The HPLC-DAD-TOF experiments were performed on an Agilent
6210 Time of Flight mass spectrometer coupled to an Agilent 1100
HPLC (Agilent Technologies). The chromatographic column and
the gradient elution program were the same previously described.
Experiments were performed in positive ion mode using a Dual-
Spray ESI source and capillary voltage 4 kV. The nebulizer gas was
at 20 psi and the drying gas flow and temperature were 6 L/min
and 350 °C, respectively. The fragmentor voltage was set at 350 V
to obtain an in-source fragmentation of the ions eluting from the
ESI spray. Spectra were recorded at 1.03 spectra/s and internally
calibrated using the reference mass at 922.009798 m/z.
2.4. Determination of stachydrine by 1H NMR
Pure stachydrine (Extrasynthese-Gene) in D2O was used to
obtain a reference proton spectrum. Different amounts (exactly
measured) of DEC, EtH2O, H2O-Res extracts, were dissolved in D2O,
range 7–12 mg of dried extract per mL. At the same time, exactly
known amounts of maleic acid (Merck, purity grade 98%) were
added as internal standard with concentration between 0.74 and
2.5 mg/mL D2O. At least three independent 1H NMR experiments,
using a 400 MHz instrument Advance 400 (Bruker, Bremen, Ger-
many), were performed for each extract. The singlet of maleic acid
at 6.25 ppm was used as reference internal standard, the Me-2
methyl group of stachydrine, at 3.03 ppm, was used as reference
signal according to a previous works (Khatib et al., 2016).
2.5. Determination of the spermidine alkaloids by HPLC-DAD
The quantitative evaluation of the main spermidine alkaloids
was performed through the use of p-OH-coumaric acid as external
standard (Sigma-Aldrich, Milan Italy, purity grade 98% by HPLC),
used to build a calibration curve at 280 nm; the linearity range
was between 0.22 μg and 2.21 μg, with R2 0.998.
2.6. Complete Freund's adjuvant-induced inflammatory arthritis
Male Sprague-Dawley rats were used; for animal's character-
ization see Di Cesare Mannelli et al. (2013a). Articular damage was
induced by injection of complete Freund's adjuvant (CFA, Sigma-
Aldrich) into the right knee joint. Briefly, the rats were slightly
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75% ethyl alcohol, and the lateral malleolus located by palpation;
then, a 28-gauge needle was inserted vertically to penetrate the
skin and turned distally for insertion into the articular cavity at the
gap between the tibiofibular and tarsal bone until a distinct loss of
resistance was felt. A volume of 50 μL of CFA was then injected
(day 0). The paw pressure and the incapacitance tests (see below)
were performed 14 days after CFA injection.
2.7. Monoiodoacetate-induced osteoarthritis
Knee osteoarthritis was induced by injection of mono-
iodoacetate (MIA, Sigma-Aldrich) into the right knee joint. On day
0, rats were slightly anesthetized by 2% isoflurane, the left leg skin
was sterilized with 75% ethyl alcohol, and the lateral malleolus
located by palpation; then, a 28-gauge needle was inserted verti-
cally to penetrate the skin and turned distally for insertion into the
articular cavity at the gap between the tibiofibular and tarsal bone
until a distinct loss of resistance was felt. Two mg MIA in 25 μL
saline was delivered into the left articular cavity. The paw pressure
and the incapacitance tests (see below) were performed on day 14.
2.8. Vegetal extracts treatments
Powdered roots and all the dried extracts were suspended in
1% CMC and administered p.o.. The following samples were eval-
uated: root powder, the decoction (DEC), the hydroalcoholic ex-
tract (EtH2O), the methylenchlorid extract (CH2Cl2) and its corre-
lated aqueous residue (H2O-Res). The doses were empirically
chosen on the bases of experimental results.
2.9. Paw pressure test
The nociceptive threshold in rats was determined with an an-
algesimeter (Ugo Basile, Varese, Italy), according to the method
described by Leighton et al. (1988). Briefly, a constantly increasing
pressure was applied to a small area of the dorsal surface of the
paw using a blunt conical probe by a mechanical device. Me-
chanical pressure was increased until vocalization or a withdrawal
reflex occurred while rats were lightly restrained. Vocalization or
withdrawal reflex thresholds were expressed in grams. Rats scor-
ing below 40 g or over 75 g during the test before drug adminis-
tration (25%) were rejected. An arbitrary cut-off value of 250 g was
adopted. Fourteen days after the operation rats were tested twice
in 30 min and mean was shown. Data were collected by an ob-
server who was blinded to the protocol. The half maximal effective
dose (ED50) was calculated on the results obtained in this test
30 min after the administration of the different vegetal products in
both CFA and MIA model.
2.10. Incapacitance test
Weight bearing changes were measured using an incapacitance
apparatus (Linton Instrumentation, UK) detecting changes in
postural equilibrium after a hind limb injury. Rats were trained to
stand on their hind paws in a box with an inclined plane (65° from
horizontal). This box was placed above the incapacitance appara-
tus. This allowed us to independently measure the weight that the
animal applied on each hind limb. The value considered for each
animal was the mean of 5 consecutive measurements. In the ab-
sence of hind limb injury, rats applied an equal weight on both
hind limbs, indicating a postural equilibrium, whereas an unequal
distribution of the weight on hind limbs indicated a monolateral
decreased pain threshold. Data are expressed as the difference
between the weight applied on the limb contralateral to the injury
and the weight applied on the ipsilateral one (Δ Weight).Statistical analyses of all behavioral results was performed as de-
cribed previously (Di Cesare Mannelli et al., 2013a).3. Results
3.1. Composition of the dried extracts (DE)
DEC sample was obtained by 1 h decoction mimicking the tra-
ditional processes used in the Arab and Greek popular medicine to
prepare samples for human applications (Moghaddasi et al., 2012;
Sher and Alyemeni, 2010). The extraction by ethanol at 70% v/v
coupled with US at low frequency was chosen as the best procedure
for recovering the largest amount of spermidine alkaloids (according
to Khatib et al., 2016) to prepare the EtH2O sample. Aiming to se-
parate the more polar alkaloid, stachydrine, from the spermidine
group, a typical fractionation process used to selectively recover li-
pophilic alkaloid from water was applied obtaining CH2Cl2 and the
H2O-Res from the fractionation of EtH2O. Fig. 1 reports the chemical
structures of the main spermidine alkaloids and of stachydrine. The
HPLC profiles at 280 nm of the four extracts obtained from caper's
root are shown in Fig. 2. The identification of the main group of
spermidine alkaloids was done by the help of mass spectrometry
according to our previous work (Khatib et al., 2016) representative
Extract Ion profiles of the positive ions (by TOF) identifying three
main isobars of glycosylated spermidine alkaloids of capparisine and
capparispine (m/z 598.27) and the corresponding free forms (m/z
436.22), together with minor isobaric forms of codonocarpine and
isocodonocarpine of monoglycosides are shown in the Supplemen-
tary Fig. S1. The corresponding mass spectra with the accurate mass
values confirm not only the presence of the alkaloids previously
isolated from this root (Fu et al., 2008) but also of several analogous.
3.2. Alkaloid content in dried extract (DE)
The evaluation of the spermidine alkaloid was carried out by
HPLC-DAD, while the stachydrine was determined by 1H NMR
experiment and the data expressed in terms of mg/g DE (Table 1).
Regarding the HPLC-DAD method the p-OH-coumaric acid was
selected as external standard. Due to the lack of commercially
available pure spermidine alkaloids, this acid was chosen in light of
the similar chromophoric group present in all the spermidine al-
kaloids of C. spinosa (Fig. 1) and determinant for defining the shape
of the correlated UV–Vis spectra. This approach, even if it does not
allow an accurate determination of each single compound, has the
advantage to be easy and suitable to perform a preliminary study on
the alkaloid composition of this root. Similar methods are applied
for the analyses of complex vegetal matrices when suitable stan-
dards are not available. The 1H NMR measurements were for de-
fining stachydrine content in the DEC, EtH2O and H2O-Res extracts
while in the CH2Cl2 sample this molecule was absent as expected
due to its high polarity. Results, obtained by published methodol-
ogies (Khatib et al., 2016) are shown in Table 1.
3.3. Effect of Capparis spinosa on CFA-induced rheumatoid arthritis
The effectiveness of Capparis spinosa was evaluated on CFA-
induced rheumatoid arthritis model in the rat. On day 14, when
CFA painful effect peaked, roots (300, 100, 30 and 3 mg kg1), DEC
(100, 30 and 3 mg kg1), EtH2O (300, 100, 30 and 3 mg kg1),
CH2Cl2 (30, 10 and 3 mg kg1) or H2O-Res (100, 30 and 3 mg kg1)
from Capparis spinosa were acutely administered p.o. and beha-
vioral tests were performed. The Paw pressure test lead us to ap-
preciate the reduced pain threshold to a mechanical noxious sti-
mulus (ipsilateral paw) in comparison to the sham þ vehicle an-
imals (Figs. 3 and 4). As shown in Fig. 3a, roots sample increased
Fig. 1. Representative chemical structures of the main spermidine alkaloids and of stachydrine in caper roots; the moiety corresponded to spermidine is shown between the
dashed lines.
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higher dose (300 mg kg1) reverted the CFA-painful effect for
30 min (Fig. 3a). DEC (100 mg kg1) completely reduced the me-
chanical hypersensitivity for 30 min whereas 30 and 3 mg kg1
significantly increased the withdrawal threshold for 60 and
30 min, respectively (Fig. 3b). EtH2O was fully effective up to
30 min administration of 300 mg kg1 (Fig. 3c). The CH2Cl2 (30–
3 mg kg1) fraction significantly lowered the pain sensitivity to a
noxious stimulus up to 30 min peaking 15 min after administra-
tion (64.270.7 g, CFþCH2Cl2 vs 44.670.5 g, CFAþvehicle)
(Fig. 4a). As depicted in Fig. 4b, the aqueous fraction (H2O-Res)
reverted mechanical hypersensitivity for 30 min at the dose of
100 mg kg1, whereas 30 mg kg1 significantly increased the
painful threshold for 60 min, completely reverting hypersensitiv-
ity 15 min after injection (65.870.7 g, CFA þEtH2O vs 44.070.6 g,
CFA þ vehicle) (Fig. 4b). ED50 values calculated on the bases of this
test (CFA, Table 2) allow to establish the following potency order:
H2O-Res4CH2Cl24DEC4roots4EtH2O.
On day 14, the difference between the weight burdened on the
contralateral and the ipsilateral limb (Δ Weight) significantly in-
creased in CFA injected animals with respect to shamþvehicle
treated rats as measured by the Incapacitance test (Figs. 3 and 4).
As depicted in Fig. 3d and f, both roots and EtH2O significantly
reduced Δ Weight in a dose-dependent manner peaking 15 min
after injection (14.373.2 g, CFAþroots 300 mg kg1 and
10.772.0 g, CFAþEtH2O 300 mg kg1) (Fig. 3d and f). Fig. 3e
shows that 30 mg kg1 DEC significantly reduced spontaneous
pain for 75 min peaking 15 min after injection (12.970.9 g,
CFAþDEC vs 60.072.5 g, CFAþvehicle). Thirty mg kg1 CH2Cl2extract induced a significant effect for 45 min peaking 15 min after
administration (4.670.3 g, CFAþCH2Cl2 extract vs 60.072.5 g,
CFAþvehicle) whereas H2O-Res, at the same dosage, statistically
lowered the hind limb bearing alterations up to 60 min (at 15 min:
57.071.3 g, CFAþH2O-Res vs 65.073.0 g, CFAþvehicle) (Fig. 4c
and d). Furthermore, 100 mg kg1 of H2O-Res significantly re-
duced spontaneous pain for 75 min fully revoking Δ Weight dif-
ference 15 min after treatment (1.272.5 g, CFAþH2O-Res vs
65.073.0 g, CFAþvehicle) (Fig. 4d).
3.4. Effect of Capparis spinosa on MIA-induced osteoarthritis
The pain reliever effect of Capparis spinosa was evaluated on
MIA-induced osteoarthritis model in the rat. On day 14, roots (300,
100, 30 and 10 mg kg1), DEC (100, 30 and 3 mg kg1), EtH2O
(300, 100, 30 and 10 mg kg1), CH2Cl2 (30, 10, 3 and 1 mg kg1) or
H2O-Res (100, 30 and 3 mg kg1) from Capparis spinosa were
acutely administered p.o. and behavioral tests were performed.
On day 14, MIA injection was able to decrease the pain
threshold in response to a mechanical noxious stimulus as mea-
sured by Paw pressure test (Figs. 5 and 6). Roots and EtH2O exerted
a similar effect. The higher dose (300 mg kg1) significantly in-
creased the weight tolerated on the ipsilateral paw of MIA-injected
rats up to 45 min peaking 15 min after injection (60.671.2 g,
MIAþroots and 59.370.6 g, MIAþEtH2O) (Fig. 5a and c). Fur-
thermore, 100 and 30 mg kg1 of roots, EtH2O and DEC showed
the same tendency in decreasing pain sensitivity.
As shown in Fig. 6a, CH2Cl2 and H2O-Res were the most effec-
tive. Thirty and 10 mg kg1 CH2Cl2 extract similarly increased the
Fig. 2. Distribution of the spermidine alkaloids and stachydrine in the tested extracts, all the profiles are at 280 nm. Dec: decoction, EtH2O: hydroalcoholic, CH2Cl2: me-
thylene chloride and H2O-Res: water residue. S: stachydrine; 1) Capparispine-26-O-gluc. (trans-cis); 2) isobar of 1 and 3; 3) Cadabicine-26-O-gluc. (trans-trans); 4 and 5
isobars of 6; 6) Capparisine (trans-trans).
Table 1
Spermidine alkaloids and stachydrine in the four extracts obtained by Caparis root.
Molecular
weight
Compounds mg/g DE
DEC EtH2O CH2CL2 H2O-Res
598.27 1-Capparispine-26-O-
gluc.
0.28 0.59 – 0.49
598.27 2-Isobar of 1 and 3 0.19 0.38 – 0.29
598.27 3-Cadabicine-26- O-gluc. 1.45 3.16 1.98 3.10
436.22 4-Isobar of 6 0.42 0.81 – 0.23
436.22 5-Isobar of 6 0.12 0.20 8.06 0.21
436.22 6-Capparisine 2.75 5.05 57.44 1.29
Total spermidine
alkaloids
5.21 10.19 67.49 5.62
Stachydrine 54.15 51.40 – 55.09
DE: dried extract. (1) Capparispine-26-O-gluc. (trans-cis); (2) isobar of 1 and 3;
(3) Cadabicine-26- O-gluc. (trans-trans); 4 and 5 isobars of 6; (6) Capparisine
(trans-trans).
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injection (63.370.7 g, MIAþCH2Cl2 30 mg kg1 and 60.870.7 g,
MIAþCH2Cl2 10 mg kg1 vs 43.370.7 g, MIAþvehicle). Thirty
mg kg1 H2O-Res displayed comparable effectiveness to the same
dosage of the CH2Cl2 fraction, whereas 100 mg kg1 significantly
increased the withdrawal threshold up to 60 min revoking pain
15 min after administration (68.370.7 g, MIAþH2O-Res vs
43.070.5 g, MIAþvehicle) (Fig. 6b). ED50 values calculated on the
bases of this test (MIA, Table 2) allow to establish the following
potency order: H2O-Res4DEC4CH2Cl24EtH2O4roots.
Incapacitance test revealed that the different weight burdenedbetween the contralateral and the ipsilateral hind limb (ΔWeight)
was significantly decreased in MIA injected rats with respect to the
sham group (Figs. 5 and 6). As depicted in Fig. 5d and f,
300 mg kg1 both roots and EtH2O reduced spontaneous pain in a
comparable manner while 100 mg kg1 roots exerted higher ef-
fectiveness 15 min after injection in comparison to the same do-
sage of EtH2O (20.370.2 g, MIAþroots vs 45.170.9 g,
MIAþEtH2O). Moreover, 100 mg kg1 of DEC exerted longer effect
being active up to 45 min (Fig. 5e). CH2Cl2 extract reduced Δ
Weight in a dose dependent-manner (Fig. 6c). Notably, the higher
dose significantly lowered hind limb bearing alterations up to
60 min peaking 15 min after administration (3.772.2 g,
MIAþCH2Cl2 extract vs 61.072.0 g, MIAþvehicle). Thirty mg kg1
H2O-Res was lower effective than the same dose of CH2Cl2 fraction
whereas 100 mg kg1 significantly decreased spontaneous pain
for 75 min (Fig. 6d).4. Discussion
The present results highlight the pain reliever effect of root
powder and four different root extracts from Capparis spinosa in
two different models of articular pain.
Alkaloids like capparisine, cadabicine in free and glycosylate
forms are known as main components of C. spinosa root (Fu et al.,
2008) together with a more polar alkaloid, stachydrine (Khatib
et al., 2016). These alkaloids are differently distributed in the four
samples. DEC and EtH2O extracts show very similar profiles at
280 nm but the total amount of spermidine alkaloids is almost
double in the latter sample, while the amount of stachydrine is
similar. After the fractionation step it was possible to obtain a
Fig. 3. CFA-induced rheumatoid arthritis. Effect of roots, DEC and EtH2O. (a), (b), (c) Response to a noxious mechanical stimulus. Roots, DEC or EtH2O were administered p.o.. Pain
threshold was evaluated on the ipsilateral paw 15, 30, 45, 60 and 75 min after treatment. (d), (e), (f) Hind limb weight bearing alteration. Roots, DEC or EtH2O of Capparis
spinosa were administered p.o. and behavioral measurements were performed 15, 30, 45, 60, 75 and 90 min after administration. Data are expressed as the difference
between the weight applied on the limb contralateral to the CFA injection and the weight applied on the ipsilateral one (Δ Weight). Behavioral measurements were
performed on day 14 after CFA administration. Each value represents the mean of 5 rats per group performed in 2 different experimental set. **Po0.01 vs shamþvehicle
treated rats; ^Po0.05 and ^^Po0.01 vs CFAþvehicle treated rats.
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7 times higher with respect to the native sample (EtH2O), mostly
composed by capparisine (6) and free of stachydrine. As expected,
in the residual water fraction the glycosylated forms, cappar-
ispine-26-O-glucoside (1) and cadabicine-26-O-glucoside (3) were
the more abundant alkaloids, together with stachydrine in a con-
centration close to that in decoction. As highlighted from thephytochemical analyses, it was possible to evaluate samples with
different alkaloid contents and ratios among the target molecules,
trying to identify the more active compounds.
The intra-articular injection of the Complete Freund's adjuvant
induced inflammatory arthritis with similar features to rheuma-
toid arthritis (Waksman, 2012). CFA-induced arthritis causes a
painful condition starting 3 days after injection and peaking on
Fig. 4. CFA - induced rheumatoid arthritis. Effect of CH2Cl2 and H2O-Res. (a), (b) Response to a noxious mechanical stimulus. CH2Cl2 or H2O-Res extracts were administered p.o..
Pain threshold was evaluated on the ipsilateral paw 15, 30, 45, 60 and 75 min after administration. (c), (d) Hind limb weight bearing alteration. CH2Cl2 or H2O-Res extracts
from Capparis spinosa were administered p.o. and behavioral measurements were performed 15, 30, 45, 60, 75 and 90 min after administration. Data are expressed as the
difference between the weight applied on the limb contralateral to the CFA injection and the weight applied on the ipsilateral one (Δ Weight). Behavioral measurements
were performed on day 14 after CFA administration. Each value represents the mean of 5 rats per group performed in 2 different experimental set. **Po0.01 vs
shamþvehicle treated rats; ^Po0.05 and ^^Po0.01 vs CFAþvehicle treated rats.
Table 2
ED50 values.
Compounds ED50 (mg kg1)
CFA, roots 15.172.4
CFA, DEC 12.571.9
CFA, EtH2O 24.473.7
CFA, CH2Cl2 4.671.0
CFA, H2ORes 0.970.5
MIA, roots 46.275.6
MIA, DEC 1.570.9
MIA, EtH2O 11.273.7
MIA, CH2Cl2 4.872.1
MIA, H2O-Res 0.470.2
ED50 values were calculated on the
Paw pressure test results 30 min
after the administration of the dif-
ferent vegetal products both in the
CFA and MIA model.
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teenth days after CFA injection, the weight tolerated on the ipsi-
lateral paw sensibly decreased. At the same time the postural
unbalance, as measure of spontaneous pain, increased in CFA-in-
jected rats. Root powder as well as root extracts are active in re-
ducing pain behaviour. The CH2Cl2 and H2O-Res extracts
(30 mg kg1) were the most potent in increasing pain threshold
and reducing spontaneous pain. DEC (100 mg kg1) showedhigher potency in comparison to EtH2O and roots (300 mg kg1).
A similar pain reliever profile was highlighted in the rat model of
osteoarthritis induced by the intra-articular injection of MIA. The
first inflammatory phase (day 7 after MIA injection) is followed by
an increasing neuropathic component leading to enhanced re-
sponses to normal or suprathreshold stimulation (allodynia- and
hyperalgesia-related measurements; Di Cesare Mannelli et al.,
2013b). On day 14, Capparis spinosa preparations relieved MIA-
dependent articular pain (both hypersensitivity and spontaneous
pain) showing efficacy also against a predominantly neuropathic
pain. The better efficacy/potency profile was shown by the CH2Cl2
and H2O-Res extracts. DEC was able to decrease mechanical hy-
persensitivity and postural unbalance at dosages lower than
EtH2O. However, the higher dose of DEC did not allow to revert the
painful condition.
Pharmacological data suggest that the enrichment in spermi-
dine alkaloids (CH2Cl2) allows to potentiate the pain reliever effect
in comparison to the less concentrated extracts DEC and EtH2O.
Surprisingly, efficacy and potency were not lost by the residual
aqueous product H2O-Res characterized by a lower concentration
of non-glycosylated spermidine alkaloids as capparisine (6) and its
isobars. It can be underlined that all these alkaloids have a macro
cyclic ring that contains a linear chain overlapped with the
structure of spermidine, a well known endogenous polyamine.
Typically, these compounds are formed by the condensation of a
nitrogen atomwith a carboxylic acid and the nucleophilic attack of
Fig. 5. MIA - induced osteoarthritis. Effect of roots, DEC and EtH2O. (a), (b), (c) Response to a noxious mechanical stimulus. Roots, DEC or EtH2O were administered p.o.. Pain
threshold was evaluated on the ipsilateral paw 15, 30, 45 and 60 min after administration. (d), (e), (f) Hind limb weight bearing alteration. Roots, DEC or EtH2O of Capparis
spinosa were administered p.o. and behavioral measurements were performed 15, 30, 45 and 60 min after administration. Data are expressed as the difference between the
weight applied on the limb contralateral to the MIA injection and the weight applied on the ipsilateral one (ΔWeight). Behavioral measurements were performed on day 14
after MIA administration. Each value represents the mean of 5 rats per group performed in 2 different experimental set. **Po0.01 vs shamþvehicle treated rats; ^Po0.05
and ^^Po0.01 vs MIAþvehicle treated rats.
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unit (Cordell, 1981).
It is well known that the use of polyamines in arthritis could be
beneficial for synovial bearing reconstruction and reduce osteolytic
activity (Iezaki et al., 2012). Moreover, continuous nociceptive sti-
mulation caused by joint inflammation leads to spinal dorsal horn'sneurons hyperexcitability inducing neuropathic pain (Fernihough
et al., 2004; Lee et al., 2011). The present results suggests that the
pain reliever effect of caper could be due to the anti-inflammatory
and protective effects of spermidine alkaloids as well as to the
presence of other phyto-chemicals able to reduce the firing of
sensitive neurons. Accordingly, Arslan et al. (2010) showed that the
Fig. 6. MIA – induced osteoarthritis. Effects of CH2Cl2 and H2O-Res. (a), (b) Response to a noxious mechanical stimulus. CH2Cl2 or H2O-Res extracts were administered p.o.. Pain
threshold was evaluated on the ipsilateral paw 15, 30, 45, 60 and 75 min after administration. (d), (e), (f) Hind limb weight bearing alteration. CH2Cl2 or H2O-Res extracts of
Capparis spinosa were administered p.o. and behavioral measurements were performed 15, 30, 45, 60, 75 and 90 min after administration. Data are expressed as the
difference between the weight applied on the limb contralateral to the MIA injection and the weight applied on the ipsilateral one (Δ Weight). Behavioral measurements
were performed on day 14 after MIA administration. Each value represents the mean of 5 rats per group performed in 2 different experimental set. **Po0.01 vs
shamþvehicle treated rats; ^Po0.05 and ^^Po0.01 vs MIAþvehicle treated rats.
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through both peripheral and central mechanisms. Finally, applying
different chromatographic methods and after a depth investigation
by mass spectrometry, the presence of other potential active com-
pounds such as quercetin or other flavonoids, which could exert
anti-oxidative activity, was excluded. Noteworthy, flavonoids are
widely distributed in the aerial parts of different plants but usually
lower amounts are found in the underground parts, as roots. An
intense oxidative state in the presence of chondrocyte necrosis has
been observed at the joint level both in MIA and CFA arthritis
models (Di Cesare Mannelli et al., 2013a). Moreover, a direct re-
lationship between persistent pain and oxidative stress has been
demonstrated (Di Cesare Mannelli et al., 2012). Several authors
suggested the relevance of the anti-oxidant effects of quercetin and
other flavonoids in the pain reliever properties of Capparis spinosa
fruit extracts (Feng et al., 2011; Zhou et al., 2010). Furthermore,
flowering buds of Capparis spinosa can counteract necrosis of
chondrocytes and trigger lowering of NO synthase and oxygen ra-
dicals in an in vitro model of articular damage (Panico et al., 2005).
Nevertheless, and according to our results, the presence of these
flavonols in caper root has not been demonstrated to date. Taking
into account stachydrine, it does not emerge a key role of this polar
alkaloid that is almost in the same amounts in DEC, EtH2O and H2O-
Res but completely absent in CH2Cl2 sample.5. Conclusions
In conclusion, Capparis spinosa root powder and its different
extracts are able to acutely relieve pain in rat models of rheuma-
toid arthritis and osteoarthritis. Our data support the traditional
use of this root against different types of pain in humans. Since the
efficacy was not influenced by the different alkaloid distribution
throughout the extracts, a real synergistic effect due to a specific
“phytochemical mixture” can be hypothesized.Acknowledgements
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